Print Page  Close Window

News Release

Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference

SAN DIEGO, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Stephen Farr, President, and Ann Rhoads, Chief Financial Officer, will present at the Oppenheimer 25th Annual Healthcare Conference in New York, NY on December 10, 2014.

Event: Oppenheimer 25th Annual Healthcare Conference
Date:   Wednesday, December 10, 2014
Place: New York City
Time: 10:55am – 11:25am

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Management will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

FPR

CONTACT: Investors
         Zack Kubow, The Ruth Group
         646.536.7020, zkubow@theruthgroup.com
Zogenix